School of Medicine
Showing 21-28 of 28 Results
Billy W. Loo, Jr., MD, PhD, DABR
Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center
Current Research and Scholarly Interests My clinical specialty is radiation treatment of thoracic cancers.
My research is on developing next-generation ultra-rapid radiation therapy technology (PHASER) and studying the radiobiological effects of FLASH treatment.
My clinical research is on advanced 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), and functional and metabolic imaging and imaging biomarkers.
Associate Professor of Biology
Current Research and Scholarly Interests Our research interests are to elucidate the contribution of chromatin to mechanisms that promote genomic integrity.
Assistant Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly Interests The Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.
Scott G. Soltys, MD
Associate Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery at the Stanford University Medical Center
Current Research and Scholarly Interests My clinical and research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of malignant and benign tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.
Jacob Haimson Professor and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly Interests artificial intelligence in medicine, Image-guided intervention, molecular imaging, biologically conformable radiation threapy (BCRT), treatment plan optimization, optimization, application of molecular imaging to radiation oncology.
Assistant Professor of Radiation Oncology
Current Research and Scholarly Interests One hallmark of cancer is that malignant cells modulate metabolic pathways to promote cancer progression. My professional interest is to investigate the causes and consequences of the abnormal metabolic phenotypes of cancer cells in response to microenvironmental stresses such as hypoxia and nutrient deprivation, with the prospect that therapeutic approaches might be developed to target these metabolic pathways to improve cancer treatment.